Autopsy report · NCT04703140

COVIDISC: Rapid Diagnostic Tests on Nasopharyngeal Swabs for the Detection of COVID-19

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“Non-significant intemedial analysis”

The sponsor’s own words in the registry.

Life of this trial

Registered 2 months before it started.
Ran for about 3 months before it stopped.
192 participants enrolled.
No results are posted on the registry.

Vital statistics

Status: Terminated
Phase: Na
Sponsor: CMC Ambroise Paré
Sponsor type: University, hospital or other
Conditions: COVID-19; SARS-CoV-2
Interventions: Rapid Diagnostic Test vs PCR
Participants: 192
Sites: 1
Countries: France

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.